Dr. Sindhu R. Srivatsal, MD

Dr. Srivatsal practices at Virginia Mason Medical Center - HOPD in Seattle, Washington.

Dr. Srivatsal's NPI, 1497878490, was assigned on April 6, 2007. Dr. Srivatsal holds Washington license MD60211101.

Dr. Srivatsal's primary practice is Virginia Mason Medical Center - HOPD, at 1100 9th Ave, Seattle, WA 98101.

Dr. Srivatsal's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dr. Srivatsal is also affiliated with Virginia Mason Medical Center. The medical group on file is Virginia Mason Medical Center. Dmand AI also links Dr. Srivatsal to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 imaging center, each named with a free account. Dr. Srivatsal's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Srivatsal practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Srivatsal's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Srivatsal's licenses on file in 2 states: Washington and Wisconsin.

CMS data shows 910 Medicare services from Dr. Srivatsal across 9 procedure codes in 2024, for 418 Medicare patients. Medicare paid $66,017 for them.

CMS counts 418 Medicare patients who saw Dr. Srivatsal in 2024. The largest group is 75 to 84, with 189 patients. 59% of them have high blood pressure, and 58% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Srivatsal's median patient age at 75, with 53% women.

In 2024, Dr. Srivatsal wrote 3,267 Medicare Part D claims for 410 patients. 90% of them were for generic drugs. CMS names the drug for 3,040 of them, across 56 drugs with 11 or more claims each, at $1,276,375 in total drug cost. In 2023, CMS named 2,851 claims across 50 drugs.

Dr. Srivatsal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Srivatsal as offering telehealth.

Dmand AI links 4 papers to Dr. Srivatsal, published from 2012 to 2014. 2014 was the busiest year, with 2. Dr. Srivatsal's most frequent co-authors are Daniel Weintraub, MD, Cyrus Parse Zabetian, MD and Stephen Ashwal, MD.

CMS Open Payments shows 18 general payments to Dr. Srivatsal from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Boston Scientific Corporation paid the most, $705.